THE LRP1 GENE POLYMORPHISM IS ASSOCIATED WITH INCREASED RISK OF METABOLIC SYNDROME PREVALENCE IN THE SERBIAN POPULATION
Vučinić N1,*, Stokić E1,2, Djan I3,4, Obreht D5, Veličković N5, Stankov K6, Djan M5
*Corresponding Author: Nataša Vučinić, Ph.D., University of Novi Sad, Faculty of Medicine, Department of Pharmacy, Hajduk Veljkova 3, 21000 Novi Sad, Serbia. Tel: +38121422760. Mobile: +381652452456. Fax: +38121450620. E-mail: natasa.vucinic@mf.uns.ac.rs
page: 51

REFERENCES

1. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414 (6865): 782-787. 2. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M. Type 2 diabetes in the young: The evolving epidemic: The International Diabetes Federation Consensus Workshop. Diabetes Care. 2004; 27(7): 1798-1811. 3. Blaha MJ, Bansal S, Rouf R, Golden SH, Blumenthal RS, Defilippis AP. A practical “ABCDE” approach to the metabolic syndrome. Mayo Clin Proc. 2008; 83(8): 932-941.4. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med. 2004; 140(3): 167-174. 5. Fujita T. Aldosterone in salt-sensitive hypertension and metabolic syndrome. J Mol Med. 2008; 86(6): 729-734. 6. Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med. 2010; 88(10): 993-1001. 7. Owen JG, Reisin E. Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: A review of evidence, meta-analysis, post hoc and guidelines publications. Curr Hypertens Rep. 2015; 17(6): 1-10. 8. O’Neill S, O’Driscoll L. Metabolic syndrome: A closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015; 16(1): 1-12. 9. Franchini M, Montagna M. Low-density lipoprotein receptor-related protein 1: New functions for an old molecule. Clin Chem Lab Med. 2011; 49(6): 967-970. 10. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – A new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med. 2006; 23(5): 469-480. 11. Evans A, Talonen H, Hense HW, Ferrario M, Sans S, Kuulasmaa K. Trends in coronary risk factors in the WHO MONICA Project. Int J Epidemiol. 2001; 30(Suppl 1):s35-s40. 12. Liu Q, Trotter J, Zhang J, Peters MM, Cheng H, Bao J, et al. Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration. J Neurosci. 2010; 30(50): 17068-17078. 13. Christoforidis M, Schober R, Krohn K. Geneticmorphologic association study: Association between the low density lipoprotein-receptor related protein (LRP1) and cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2005; 31(1): 11-19. 14. Vormittag R, Bencur P, Ay C, Tengler T, Vukovich T, Quehenberger P, et al. Low-density lipoprotein receptor-related protein 1 polymorphism 663 C>T affects clotting factor VIII activity and increases the risk of venous thromboembolism. J Thromb Haemost. 2007; 5(3): 497-502. 15. Masson O, Chavey C, Dray C, Meulle A, Daviaud D, Quilliot D, et al. LRP1 receptor controls adipogen esis and is up-regulated in human and mouse obese adipose tissue. PLoS One. 2009; 4(10): e7422. doi: 10.1371/journal. pone.0007422. 16. Liu Q, Zhang J, Zerbinatti C, Zhan Y, Kolber BJ, Herz J, et al. Lipoprotein receptor LRP1 regulates leptin signaling and energy homeostasis in the adult central nervous system. PLoS Biol. 2011; 9(1): 1-9. 17. Niemeier A, Kassem M, Toedter K, Wendt D, Ruether W, Beisiegel U, et al. Expression of LRP1 by human osteoblasts: A mechanism for the delivery of lipo-proteins and vitamin K1 to bone. J Bone Miner Res. 2005; 20(2): 283-293. 18. Meng H, Chen G, Zhang X, Wang Z, Thomas D, Giordano T, et al. Stromal LRP1 in lung adenocarcinoma predicts clinical outcome. Clin Cancer Res. 2011; 17(8): 2426-2433. 19. Neels JG, Bovenschen N, van Zonneveld AJ, Lenting PJ. Interaction between factor VIII and LDL receptorrelated protein. Modulation of coagulation? Trends Cardiovasc Med. 2000; 11(1): 251-257. 20. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer’s disease. Neurology. 1997; 49(1): 56-61. 21. Clemente-Postigo M, Queipo-Ortuno MI, FernandezGarcia D, Gomez-Huelgas R, Tinahones FJ, Cardona F. Adipose tissue gene expression of factors related to lipid processing in obesity. PLoS One. 2011; 6(9): e24783. doi: 10.1371/journal.pone.0024783. 22. Hofmann SM, Zhou L, Perez-Tilve D, Greer T, Grant E, Wancata L, et al. Adipocyte LDL receptor-related protein-1 expression modulates postprandial lipid transport and glucose homeostasis in mice. J Clin Invest. 2007; 117(11): 3271-3282. 23. Hatanaka Y, Kamino K, Fukuo K, Mitsuda N, Nishiwaki-Ueda Y, Sato N, et al. Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer’s disease in a Japanese population. Clin Genet. 2000; 58(4): 319-323. 24. A consensus statement from the International Diabetes Federation. Diabet Med. 2006; 23(4): 469-480. 25. Kassi E, Pervanidou P, Chrousos G. Metabolic syndrome: Definitions and controversies. BMC Med. 2011; 9: 48. doi: 10.1186/1741-7015-9-48. 26. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative centrifuge. Clin Chem. 1972; 18(6): 499-502. 27. Sambrook JF, Russel DW. Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press, 2001. 28. StatSoft, Inc. STATISTICA (data analysis software system), version 10, 2011. www.statsoft.com 29. http://www.ensembl.org/Homo_sapiens/Variation/ Population?db=core;r=12:57540765-57541765;v= rs2306692;vdb=variation;vf=1890007#102187_ tablePanel. 30. Panza F, D’Introno A, Colacicco AM, Capurso C, Basile AM, Capurso S, et al. Regional European differences in allele and genotype frequencies of low density lipoprotein receptor-related protein 1 poly morphism in Alzheimers disease. Am J Med Genet Part B Neuropsychiatr Genet. 2004; 126B(1): 69-73. 31. Beneš P, Jurajda M, Žaloudík J, Izakovičová-Hollá L, Vácha J. C766T low-density lipoprotein receptorrelated protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer. Breast Cancer Res. 2003; 5(3):R77-R81. 32. Vučinić N, Djan I, Stokić E, Božin B, Obreht D, Stankov K, et al. Different associations of apoE gene polymorphism with metabolic syndrome in the Vojvodina Province (Serbia). Molec Biol Rep. 2014; 41(8): 5221-5227.



Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006